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Inﬂammatory bowel disease (IBD) is the main risk factor for developing colorectal cancer 
which is common in patients of all ages. 5-Aminosalicylic acid (5-ASA), structurally relat ed 
to the salicylates, is highly active in the treatment of IBD with minor side effects. In this 
study, the synthesis of galactose and fructose esters of 5-ASA was planned to evaluate the 
role of glycoconjugation on the bioactivity of the parent drug. The antibacterial activity of the 
new compounds were evaluated against two Gram-negative and two Gram-positive species of 
bacteria, with a notable effect observed against Staphylococcus aureus and Escherichia coli in 
comparisons with the 5-ASA. Cytotoxicity testing over HT-29 and 3T3 cell lines indicated 
that the toxicity of the new products against normal cells was signiﬁcantly reduced compared 
with the original drug, whereas their activity against cancerous cells was slightly decreased. 
The anti-inﬂammatory activity test in RAW264.7 macrophage cells indicated that the 
inhibition of nitric oxide by both of the monosaccharide conjugated derivatives was slight ly 
improved in comparison with the non-conjugated drug. 
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